AYTU BIOPHARMA, INC: 10-Q filed 2019-05-14

Name: AYTU BIOPHARMA, INC: 10-Q filed 2019-05-14
Creator: AYTU BIOPHARMA, INC

What AYTU BIOPHARMA, INC reported in its quarterly report filed 2019-05-14 (fiscal Q3 2019): 38 published measures, 108 facts as tagged in accession 0001654954-19-005839.

This filing

Form: 10-Q (quarterly report)
Filed: 2019-05-14
Fiscal period: fiscal Q3 2019
Accession: 0001654954-19-005839 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AYTU BIOPHARMA, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-03-31	38,338,067	USD
At 2018-06-30	21,060,093	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-03-31	22,300,888	USD
At 2018-06-30	7,635,588	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-03-31	16,037,179	USD
At 2018-12-31	19,897,863	USD
At 2018-09-30	10,130,136	USD
At 2018-06-30	13,424,505	USD
At 2018-03-31	12,750,327	USD
At 2017-12-31	3,030,586	USD
At 2017-09-30	6,352,941	USD
At 2017-06-30	3,999,816	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2019-03-31	14,647,402	USD
At 2018-06-30	7,012,527	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	-4,495,862	USD	90
2018-07-01 to 2019-03-31	-12,600,007	USD	274
2018-10-01 to 2018-12-31	-4,657,662	USD	92
2018-07-01 to 2018-09-30	-3,446,483	USD	92
2018-01-01 to 2018-03-31	-2,817,712	USD	90
2017-07-01 to 2018-03-31	-10,734,432	USD	274
2017-10-01 to 2017-12-31	-3,672,678	USD	92
2017-07-01 to 2017-09-30	-4,245,042	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	-10,357,501	USD	274
2017-07-01 to 2018-03-31	-11,396,982	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	59,848	USD	274
2017-07-01 to 2018-03-31	74,707	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	2,377,792	USD	90
2018-07-01 to 2019-03-31	5,604,612	USD	274
2018-01-01 to 2018-03-31	607,473	USD	90
2017-07-01 to 2018-03-31	2,734,995	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	18,958,549	USD	274
2017-07-01 to 2018-03-31	22,683,329	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	-965,877	USD	274
2017-07-01 to 2018-03-31	-82,092	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-03-31	-91,857,599	USD
At 2018-06-30	-79,257,592	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-03-31	219,177	USD
At 2018-06-30	218,684	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	121,979	USD	274
2017-07-01 to 2018-03-31	288,010	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	-4,298,638	USD	90
2018-07-01 to 2019-03-31	-12,266,642	USD	274
2018-01-01 to 2018-03-31	-7,524,622	USD	90
2017-07-01 to 2018-03-31	-15,873,601	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-03-31	18,458,979	USD
At 2018-06-30	9,470,291	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	194,703	USD	90
2018-07-01 to 2019-03-31	398,833	USD	274
2018-01-01 to 2018-03-31	186,629	USD	90
2017-07-01 to 2018-03-31	572,155	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-03-31	4,503,756	USD
At 2018-06-30	3,394,778	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-03-31	2,131,251	USD
At 2018-06-30	2,119,672	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2019-03-31	226,944	USD
At 2018-06-30	245,944	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2019-03-31	1,376,358	USD
At 2018-06-30	578,782	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	6,676,430	USD	90
2018-07-01 to 2019-03-31	17,871,254	USD	274
2018-01-01 to 2018-03-31	8,132,095	USD	90
2017-07-01 to 2018-03-31	18,608,596	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2019-03-31	1,530,083	USD
At 2018-06-30	1,338,973	USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	616,853	USD	90
2018-07-01 to 2019-03-31	1,552,950	USD	274
2018-01-01 to 2018-03-31	1,136,833	USD	90
2017-07-01 to 2018-03-31	1,809,445	USD	274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	5,368,762	USD	90
2018-07-01 to 2019-03-31	13,991,516	USD	274
2018-01-01 to 2018-03-31	4,637,495	USD	90
2017-07-01 to 2018-03-31	13,809,264	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	108,901	USD	90
2018-07-01 to 2019-03-31	413,808	USD	274
2018-01-01 to 2018-03-31	114,141	USD	90
2017-07-01 to 2018-03-31	-22,391	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-03-31	12,848,499	shares
At 2018-06-30	1,794,762	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2019-03-31	107,893,259	USD
At 2018-06-30	92,681,918	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2019-03-31	5,134,795	USD
At 2018-06-30	0	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-03-31	381,000	USD
At 2018-06-30	540,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-03-31	19,430,767	USD
At 2018-06-30	11,120,086	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2019-03-31	772,140	USD
At 2018-06-30	185,882	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-03-31	804,840	USD
At 2018-06-30	440,009	USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	1,974,213	USD	274
2017-07-01 to 2018-03-31	1,975,448	USD	274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	575,117	USD	90
2018-07-01 to 2019-03-31	1,561,137	USD	274
2018-01-01 to 2018-03-31	387,606	USD	90
2017-07-01 to 2018-03-31	1,156,258	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	0	USD	90
2018-07-01 to 2019-03-31	0	USD	274
2018-01-01 to 2018-03-31	1,753,568	USD	90
2017-07-01 to 2018-03-31	1,753,568	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2019-01-01 to 2019-03-31	-197,224	USD	90
2018-07-01 to 2019-03-31	-333,365	USD	274
2018-01-01 to 2018-03-31	4,706,910	USD	90
2017-07-01 to 2018-03-31	5,139,169	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	797,576	USD	274
2017-07-01 to 2018-03-31	204,437	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-07-01 to 2019-03-31	191,110	USD	274
2017-07-01 to 2018-03-31	-428,401	USD	274

Inspect the source

Entity: AYTU BIOPHARMA, INC / CIK 0001385818
Captured: 2026-09-20T07:58:53.461Z
SEC response SHA-256: 3b664ab8156647d48cbdda6c8eb0b5f1ac4147c50f45c9bb53fa74b58565a69b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001385818.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))